Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent.
from Reuters: Health News https://ift.tt/2LtkMo7
0 comments:
Post a Comment